Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis

Clinical trial NCT00677092 · COMPLETED

Trial details

NCT number: NCT00677092
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nephrogenic Systemic Fibrosis

Start date: 2007-12-01
Primary completion: 2009-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.